156 related articles for article (PubMed ID: 26944142)
1. Opsoclonus in a patient with increased titers of anti-GAD antibody provides proof for the conductance-based model of saccadic oscillations.
Shaikh AG; Wilmot G
J Neurol Sci; 2016 Mar; 362():169-73. PubMed ID: 26944142
[TBL] [Abstract][Full Text] [Related]
2. Gaze-holding and anti-GAD antibody: prototypic heterogeneous motor dysfunction in immune disease.
Theeranaew W; Wang F; Ghasia FF; Wilmot G; Shaikh AG
Cerebellum; 2022 Feb; 21(1):55-63. PubMed ID: 33977497
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic seesaw nystagmus and opsoclonus provides evidence for hyperexcitable reciprocally innervating mesencephalic network.
Rizvi MT; Cameron L; Kilbane C; Shaikh AG
J Neurol Sci; 2018 Jul; 390():239-245. PubMed ID: 29801897
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous downbeat nystagmus as a clue for the diagnosis of ataxia associated with anti-GAD antibodies.
Vale TC; Pedroso JL; Alquéres RA; Dutra LA; Barsottini OG
J Neurol Sci; 2015 Dec; 359(1-2):21-3. PubMed ID: 26671081
[TBL] [Abstract][Full Text] [Related]
5. Potential role of anti-GAD antibodies in abnormal eye movements.
Tilikete C; Vighetto A; Trouillas P; Honnorat J
Ann N Y Acad Sci; 2005 Apr; 1039():446-54. PubMed ID: 15826997
[TBL] [Abstract][Full Text] [Related]
6. Gravity-Independent Upbeat Nystagmus in Syndrome of Anti-GAD Antibodies.
Feldman D; Otero-Millan J; Shaikh AG
Cerebellum; 2019 Apr; 18(2):287-290. PubMed ID: 30136028
[TBL] [Abstract][Full Text] [Related]
7. Disabling Central Paroxysmal Positioning Upbeat Nystagmus and Vertigo Associated With the Presence of Anti-Glutamic Acid Decarboxylase Antibodies.
Martins AI; Carvalho JN; Amorim AM; Geraldo A; Eggenberger E; Lemos J
J Neuroophthalmol; 2018 Mar; 38(1):32-35. PubMed ID: 28767521
[TBL] [Abstract][Full Text] [Related]
8. A rare saccade velocity profile in Stiff-Person Syndrome with cerebellar degeneration.
Zivotofsky AZ; Siman-Tov T; Gadoth N; Gordon CR
Brain Res; 2006 Jun; 1093(1):135-40. PubMed ID: 16725126
[TBL] [Abstract][Full Text] [Related]
9. Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase.
Markakis I; Alexiou E; Xifaras M; Gekas G; Rombos A
Clin Neurol Neurosurg; 2008 Jun; 110(6):619-21. PubMed ID: 18433986
[TBL] [Abstract][Full Text] [Related]
10. Eye movements in children with opsoclonus-polymyoclonus.
Shawkat FS; Harris CM; Wilson J; Taylor DS
Neuropediatrics; 1993 Aug; 24(4):218-23. PubMed ID: 8232781
[TBL] [Abstract][Full Text] [Related]
11. Vertical nystagmus associated with glutamic acid decarboxylase antibodies responding to cyclophosphamide.
Baizabal-Carvallo JF; Alonso-Juarez M
J Neuroimmunol; 2018 Apr; 317():5-7. PubMed ID: 29501085
[TBL] [Abstract][Full Text] [Related]
12. Anti-glutamic acid decarboxylase antibody positive neurological syndromes.
Tohid H
Neurosciences (Riyadh); 2016 Jul; 21(3):215-22. PubMed ID: 27356651
[TBL] [Abstract][Full Text] [Related]
13. Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity.
Rakocevic G; Raju R; Dalakas MC
Arch Neurol; 2004 Jun; 61(6):902-4. PubMed ID: 15210528
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to glutamic acid decarboxylase in downbeat nystagmus.
Antonini G; Nemni R; Giubilei F; Gragnani F; Ceschin V; Morino S; Bucci E; Accornero N
J Neurol Neurosurg Psychiatry; 2003 Jul; 74(7):998-9. PubMed ID: 12810806
[TBL] [Abstract][Full Text] [Related]
15. Physiology and pathology of saccades and gaze holding.
Shaikh AG; Ghasia FF
NeuroRehabilitation; 2013; 32(3):493-505. PubMed ID: 23648604
[TBL] [Abstract][Full Text] [Related]
16. Anti-GAD antibodies and periodic alternating nystagmus.
Tilikete C; Vighetto A; Trouillas P; Honnorat J
Arch Neurol; 2005 Aug; 62(8):1300-3. PubMed ID: 16087772
[TBL] [Abstract][Full Text] [Related]
17. Opsoclonus Following Downbeat Nystagmus in Absence of Visual Fixation in Multiple System Atrophy: Modulation and Mechanisms.
Lee JY; Kwon E; Kim HJ; Choi JY; Oh HJ; Kim JS
Cerebellum; 2021 Oct; 20(5):724-733. PubMed ID: 31838647
[TBL] [Abstract][Full Text] [Related]
18. [Autoantibodies to GAD and autoimmune-mediated neurological diseases].
Mitoma H; Mizusawa H
Nihon Rinsho; 2013 May; 71(5):921-6. PubMed ID: 23777105
[TBL] [Abstract][Full Text] [Related]
19. Strabismus and Micro-Opsoclonus in Machado-Joseph Disease.
Ghasia FF; Wilmot G; Ahmed A; Shaikh AG
Cerebellum; 2016 Aug; 15(4):491-7. PubMed ID: 26306823
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological advances in the treatment of neuro-otological and eye movement disorders.
Strupp M; Brandt T
Curr Opin Neurol; 2006 Feb; 19(1):33-40. PubMed ID: 16415675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
